AtriCure Inc (NAS:ATRC)
$ 23.14 0.51 (2.25%) Market Cap: 1.12 Bil Enterprise Value: 1.09 Bil PE Ratio: 0 PB Ratio: 2.45 GF Score: 72/100

AtriCure Inc at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 03:00PM GMT
Release Date Price: $49.01 (+2.27%)
Unidentified Analyst

(technical difficulty) for Medical Devices at Bank of America. Thanks for joining the AtriCure presentation this morning with Mike Carrel, CEO, and I will hand it off to him for the presentation. Thanks.

Michael H. Carrel
AtriCure, Inc. - CEO, President & Director

All right. Do we have the presentation? As we're waiting for the presentation. My name is Mike Carrel, President and CEO of AtriCure. And thank you to BofA for having us here today.

All right. Well, again, Mike Carrel from AtriCure. And again, thank you to BofA for having us here today. See how quickly we can go through the forward-looking statements. So -- for those of you that don't know -- and I look around and I see many people that know AtriCure incredibly well out there today. But for those of you that don't know, we're really focused on helping those patients that have really complex forms of atrial fibrillation. And we've gotten into the space of also improving pain after surgery with the non-opioid cryo device that has actually helped out thousands and thousands

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot